Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Background: Erythropoietin-stimulating agent (ESA) hyporesponsiveness is commonly observed in patients with anemia secondary to chronic kidney disease (CKD). Because of its complexity, a global consensus on how we should define ESA hyporesponsiveness remains unavailable. The reported prevalence and...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Karger Publishers
2022-01-01
|
| coleção: | Kidney Diseases |
| Assuntos: | |
| Acesso em linha: | https://www.karger.com/Article/FullText/521162 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|